Catalyst Funds Management Pty Ltd Purchases New Holdings in Elevance Health, Inc. $ELV

Catalyst Funds Management Pty Ltd acquired a new stake in shares of Elevance Health, Inc. (NYSE:ELV) in the 4th quarter, HoldingsChannel reports. The firm acquired 1,880 shares of the company’s stock, valued at approximately $659,000.

Several other institutional investors have also added to or reduced their stakes in the company. Life Cycle Investment Partners Ltd acquired a new position in Elevance Health during the fourth quarter valued at approximately $30,710,000. Jefferies Financial Group Inc. raised its position in Elevance Health by 498.0% during the fourth quarter. Jefferies Financial Group Inc. now owns 78,397 shares of the company’s stock valued at $27,482,000 after purchasing an additional 65,288 shares in the last quarter. Americana Partners LLC raised its position in Elevance Health by 2.7% during the fourth quarter. Americana Partners LLC now owns 1,249 shares of the company’s stock valued at $438,000 after purchasing an additional 33 shares in the last quarter. LSV Asset Management raised its position in Elevance Health by 464.7% during the fourth quarter. LSV Asset Management now owns 46,664 shares of the company’s stock valued at $16,358,000 after purchasing an additional 38,400 shares in the last quarter. Finally, Keudell Morrison Wealth Management acquired a new position in Elevance Health during the fourth quarter valued at approximately $1,764,000. 89.24% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have commented on ELV. Jefferies Financial Group lowered their price objective on shares of Elevance Health from $395.00 to $391.00 and set a “buy” rating for the company in a research report on Monday, April 20th. Barclays boosted their price objective on shares of Elevance Health from $393.00 to $408.00 and gave the company an “overweight” rating in a research report on Friday, April 24th. UBS Group upped their price target on shares of Elevance Health from $400.00 to $460.00 and gave the stock a “buy” rating in a report on Friday. Mizuho upped their price target on shares of Elevance Health from $385.00 to $435.00 and gave the stock an “outperform” rating in a report on Wednesday. Finally, Guggenheim upped their price target on shares of Elevance Health from $396.00 to $399.00 and gave the stock a “buy” rating in a report on Friday, April 24th. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $399.32.

Elevance Health Stock Performance

NYSE ELV opened at $394.41 on Monday. The company has a quick ratio of 1.48, a current ratio of 1.48 and a debt-to-equity ratio of 0.70. The stock has a fifty day simple moving average of $333.81 and a 200 day simple moving average of $336.41. Elevance Health, Inc. has a twelve month low of $273.71 and a twelve month high of $408.00. The company has a market capitalization of $85.65 billion, a price-to-earnings ratio of 16.78, a PEG ratio of 2.23 and a beta of 0.66.

Elevance Health (NYSE:ELV) last issued its quarterly earnings results on Wednesday, April 22nd. The company reported $12.58 earnings per share for the quarter, topping analysts’ consensus estimates of $10.74 by $1.84. Elevance Health had a return on equity of 15.58% and a net margin of 2.62%.The firm had revenue of $49.49 billion during the quarter, compared to the consensus estimate of $48.21 billion. During the same period last year, the business posted $11.97 EPS. The business’s revenue was up 1.5% compared to the same quarter last year. Elevance Health has set its FY 2026 guidance at 19.850- EPS. Sell-side analysts expect that Elevance Health, Inc. will post 26.91 EPS for the current year.

Elevance Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Wednesday, June 10th will be given a dividend of $1.72 per share. This represents a $6.88 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend is Wednesday, June 10th. Elevance Health’s dividend payout ratio is 29.26%.

Elevance Health Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.